Search: onr:"swepub:oai:prod.swepub.kib.ki.se:142578421" > One-month dual anti...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05089naa a2200433 4500 | |
001 | oai:DiVA.org:umu-228567 | |
003 | SwePub | |
008 | 240820s2024 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2285672 URI |
024 | 7 | a https://doi.org/10.1016/j.amjcard.2024.07.0102 DOI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a Bajraktari, Ganiu Umeå universitet,Institutionen för folkhälsa och klinisk medicin,Clinic of Cardiology, University Clinical Centre of Kosova, Kosovo, Prishtina; Medical Faculty, University of Prishtina, Kosovo, Prishtina4 aut0 (Swepub:umu)gaba0006 |
245 | 1 0 | a One-month dual antiplatelet therapy reduces major bleeding compared with longer-term treatment without excess stent thrombosis :b a systematic review and meta-analysis of randomized clinical trials |
264 | 1 | b Elsevier,c 2024 |
338 | a electronic2 rdacarrier | |
520 | a Dual antiplatelet therapy (DAPT) remains the gold standard in patients who underwent percutaneous coronary intervention (PCI). This meta-analysis aims to evaluate the clinical safety of 1-month DAPT followed by aspirin or a P2Y12 receptor inhibitor after PCI with drug-eluting stents (DES). We searched PubMed, MEDLINE, Embase, Scopus, Google Scholar, Cochrane Central Registry, and ClinicalTrials.gov databases and identified 5 randomized controlled trials with 29,831 patients who underwent PCI with DES and compared 1-month versus >1-month DAPT. The primary end point was major bleeding, and the co-primary end point was stent thrombosis. The secondary end point included all-cause mortality, cardiovascular death, myocardial infarction, stroke, and major adverse cardiovascular or cerebrovascular events. Compared with >1-month DAPT, the 1-month DAPT was associated with a lower rate of major bleeding (odds ratio [OR] 0.66, 95% confidence interval [CI] 0.45 to 0.97, p = 0.03, I2 = 71%), whereas stent thrombosis had a similar rate in both study groups (OR 1.08, 95% CI 0.81 to 1.44, p = 0.60, I2 = 0.0%). The study groups had similar risks for all-cause mortality (OR 0.89, 95% CI 0.77 to 1.04, p = 0.14, I2 = 0.0%), cardiovascular death (OR 0.84, 95% CI 0.59 to 1.19, p = 0.32, I2 = 0.0%), myocardial infarction (OR 1.04, 95% CI 0.89 to 1.21, p = 0.62, I2 = 0.0%), and stroke (OR 0.82, 95% CI 0.64 to 1.05, p = 0.11, I2 = 6%). The risk of major adverse cardiovascular or cerebrovascular events was lower (OR 0.86, 95% CI 0.76 to 0.97, p = 0.02, I2 = 25%) in the 1-month DAPT compared with >1-month DAPT. In conclusion, in patients who underwent PCI with DES, 1-month DAPT followed by aspirin or a P2Y12 receptor inhibitor reduced major bleeding with no risk of increased thrombotic risk compared with longer-term DAPT. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a acute coronary syndrome | |
653 | a dual antiplatelet therapy | |
653 | a percutaneous coronary intervention | |
653 | a stable coronary artery disease | |
700 | 1 | a Bytyci, Ibadeteu Umeå universitet,Institutionen för folkhälsa och klinisk medicin,Clinic of Cardiology, University Clinical Centre of Kosova, Kosovo, Prishtina; Medical Faculty, University of Prishtina, Kosovo, Prishtina4 aut0 (Swepub:umu)ibby0002 |
700 | 1 | a Abdyli, Gencu Clinic of Cardiology, University Clinical Centre of Kosova, Kosovo, Prishtina; Medical Faculty, University of Prishtina, Kosovo, Prishtina4 aut |
700 | 1 | a Ibrahimi, Pranverau Umeå universitet,Institutionen för folkhälsa och klinisk medicin,Clinic of Cardiology, University Clinical Centre of Kosova, Kosovo, Prishtina4 aut0 (Swepub:umu)prib0001 |
700 | 1 | a Bajraktari, Artanu Umeå universitet,Institutionen för folkhälsa och klinisk medicin,Clinic of Cardiology, University Clinical Centre of Kosova, Kosovo, Prishtina4 aut0 (Swepub:umu)arba0019 |
700 | 1 | a Karahoda, Ronau Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Prague, Czech Republic4 aut |
700 | 1 | a Elezi, Shpendu Clinic of Cardiology, University Clinical Centre of Kosova, Kosovo, Prishtina; Medical Faculty, University of Prishtina, Kosovo, Prishtina4 aut |
700 | 1 | a Henein, Michael Y.u Umeå universitet,Institutionen för folkhälsa och klinisk medicin4 aut0 (Swepub:umu)mihe0015 |
710 | 2 | a Umeå universitetb Institutionen för folkhälsa och klinisk medicin4 org |
773 | 0 | t American Journal of Cardiologyd : Elsevierg 227, s. 91-97q 227<91-97x 0002-9149x 1879-1913 |
856 | 4 | u https://doi.org/10.1016/j.amjcard.2024.07.010y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1890764/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-228567 |
856 | 4 8 | u https://doi.org/10.1016/j.amjcard.2024.07.010 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.